Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Jun 09, 2026
TickeronGET DAILY SIGNALS
Leidos (LDOS) Delivers Solid Q1 2026 Results With Raised Guidance and Fresh Contract Wins

Leidos (LDOS) Delivers Solid Q1 2026 Results With Raised Guidance and Fresh Contract Wins

Key Takeaways

  • Leidos reported strong Q1 2026 results with revenue growth and an earnings beat, leading to raised full-year guidance.
  • The company secured multiple major U.S. government contracts in defense and IT modernization during recent weeks.
  • Analyst sentiment shows mixed signals, including a recent downgrade amid broader stock price pressure.
  • Backlog reached $48.4 billion, underscoring a robust pipeline of future work.
  • Focus remains on the company's North Star 2030 growth strategy and integration of recent acquisitions.

Current Market Snapshot

In recent weeks, LDOS shares have traded within a range influenced by broader market dynamics and company-specific developments. The stock has experienced downward pressure since the start of the year, reflecting a combination of macroeconomic factors and sector-specific considerations. Despite this, investor attention has centered on the defense contractor's contract wins and operational performance. Trading volumes have remained consistent with typical patterns for the name, and the shares continue to draw interest from those monitoring government spending trends in national security and technology sectors.

Recent Developments Driving LDOS Price Action

Leidos delivered its first-quarter 2026 earnings on May 5, reporting revenue of $4.4 billion, up 4% year-over-year, and non-GAAP diluted earnings per share of $3.13, exceeding consensus estimates. The company also raised its full-year 2026 revenue guidance to a range of $18.0 billion to $18.4 billion and increased its non-GAAP EPS outlook to $12.10–$12.50. These results contributed to initial positive sentiment, though subsequent price action reflected broader market conditions and other factors.

Contract announcements provided additional catalysts. On May 12, Leidos received a $2.7 billion U.S. Army award for hypersonic weapons production support. Later in the month, the company announced four awards under the U.S. Department of State’s Evolve IT modernization contract. In early June, Leidos introduced a new SATCOM tool aimed at enhancing combat connectivity. Additional awards included an $869 million Army contract and a $456 million agreement for wellbeing services management for the Department of Defense.

On the analyst front, Jefferies downgraded the stock to Hold on June 3, citing lower expectations and setting a price target of $140. Other firms had previously adjusted targets downward in May, contributing to sentiment shifts. Jim Cramer publicly commented on the stock’s decline, noting it appeared disconnected from fundamentals. The company completed the Entrust acquisition, which management described as immediately accretive, and declared a quarterly dividend of $0.43 per share. Backlog stood at $48.4 billion at quarter-end, supporting visibility into future revenue.

These developments collectively shaped trading patterns, with contract momentum offset by the downgrade and prevailing market pressures on defense names. I also checked this using Tickeron’s AI Screener to see how LDOS compares to others in the industry.

Exploring AI-Driven Trading Insights

Tickeron’s Trending AI Robots page highlights a selection of high-performing artificial intelligence trading bots drawn from hundreds available across its platform. These bots execute trades on thousands of different tickers using varied strategies, timeframes, and performance metrics. Only those demonstrating the strongest suitability for prevailing market conditions earn placement in the curated Trending AI Robots section. The featured options showcase diverse trading styles and statistical profiles to appeal to a wide range of investor preferences. For more details on current selections, visit Trending AI Robots.

2026 Outlook and Key Factors to Monitor

Investors may watch the continued execution of Leidos’ North Star 2030 strategy, which emphasizes growth in national security, digital modernization, and health sectors. Integration of the Entrust acquisition and realization of associated synergies represent key operational milestones through the year. Government budget allocations for defense and IT modernization programs will influence contract flow and revenue visibility. Macroeconomic conditions, including interest rates and federal spending priorities, could affect overall sentiment and valuation multiples. Competitive positioning in hypersonic technology, satellite communications, and secure IT solutions may also shape long-term opportunities. Regulatory developments around acquisitions and contract awards remain relevant considerations for the balance of 2026. From what I see, monitoring these elements will be important as the year progresses.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LDOS

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


LDOS in upward trend: price rose above 50-day moving average on October 22, 2026

LDOS moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 23 of 30 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on LDOS as a result. In 41 of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.

The Moving Average Convergence Divergence (MACD) for LDOS just turned positive on October 12, 2026. Looking at past instances where LDOS's MACD turned positive, the stock continued to rise in 29 of 42 cases over the following month. The odds of a continued upward trend are 69%.

The 10-day moving average for LDOS crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.

Following a +2.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where LDOS advanced for three days, in 216 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LDOS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

LDOS broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for LDOS entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. LDOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.396) is normal, around the industry mean (2.821). P/E Ratio (13.142) is within average values for comparable stocks, (17.971). Projected Growth (PEG Ratio) (0.970) is also within normal values, averaging (2.284). Dividend Yield (0.012) settles around the average of (0.172) among similar stocks. P/S Ratio (0.943) is also within normal values, averaging (139.965).

The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 10.54B. The market cap for tickers in the group ranges from 100 to 242.89B. IBM holds the highest valuation in this group at 242.89B. The lowest valued company is ARSC at 100.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was -1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -11%. SGRX experienced the highest price growth at 89%, while OPNW experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was 43%. For the same stocks of the Industry, the average monthly volume growth was 15% and the average quarterly volume growth was 25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 57
Price Growth Rating: 60
SMR Rating: 74
Profit Risk Rating: 92
Seasonality Score: 16 (-100 ... +100)
View a ticker or compare two or three
LDOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of scientific, engineering, systems integration and technical services and solutions

Industry InformationTechnologyServices

Industry
Information Technology Services
Address
1750 Presidents Street
Phone
+1 571 526-6000
Employees
47000
Web
https://www.leidos.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
AstraZeneca reported Q1 2026 total revenue of $15.3 billion, up 8% at constant exchange rates (CER, adjusting for currency fluctuations), beating consensus estimates around $14.8 billion. Core earnings per share (EPS) rose 5% to $2.58 at CER, amid a 12% increase in core operating profit.
Consensus estimates call for Q3 FY2026 revenue of approximately $3.37 billion, in line with the company's guidance midpoint of $3.35 billion. Non-GAAP earnings per share (EPS) expected at $9.16, edging above the guided midpoint of $9.08.